Pacific Northwest Cardiovascular Summit

Image of the Willamette River and the city of Portland at twilight.

Join us at the next annual Pacific Northwest Cardiovascular Summit to learn from internationally renowned faculty who address the state of the art in clinical cardiology. Lectures and discussions address topics including heart failure, electrophysiology, prevention, imaging, structural heart disease and peripheral vascular disease.

A conference in a setting like no other

If you are up for exploring, the city has much to offer. Zip over to Washington Park for the International Rose Test Garden, Portland Japanese Gardens, Oregon Zoo and spectacular views of Mount Hood. Sample craft beer — Portland has 70+ craft breweries. Drive 40 minutes to Oregon’s Willamette Valley wine country, populated with 500 wineries. Breathe the fresh Pacific Northwest air and relax, surrounded by lush forest, rivers and mountains.


This conference has been postponed until 2022.

Event archive


Friday, September 6

8:30 a.m.: Welcome

8:45 a.m.: Is a Sea change Underway? Less Antiplatelets? More Antithrombotics?
Joaquin Cigarroa, M.D.

9:15 a.m.: Can we Ablate VF?
Samuel Asirvantham

9:45 a.m.: Panel Q & A

10:30 a.m.: With the Low Risk TAVR Trial Outcomes, Who Should Still be Treated with Surgery?
Michael Mack, M.D., F.A.C.C.

11 a.m.: How to make the best of what you have, lessons learned from Transcatheter valve therapies
Firas Zahr, M.D.

11:30 a.m.: Panel Q & A

1 p.m.: The Future of Hypertrophic Cardiomyopathy
Stephen Heitner, M.D.

1:30 p.m.: Cardio-Oncology: Understanding Interplay Between Cancer and Heart Disease for Improved Outcomes
Maros Ferencik, M.D., Ph.D.

2 p.m.: Panel Q & A

2:45 p.m.: Update on Devices for Peripheral Interventions
Ehrin Armstrong, M.D.

3:15 p.m.: Learning from Failure: Novel Approaches to Exercise Training in Heart Failure with Preserved Ejection Fraction
Satyam (Tom) Sarma

3:45 p.m.: Panel Q & A

4:15 p.m.: Treatment of Cardiac Arrhythmias Past and Present and a Glimpse into the Future
Melvin Scheinman, M.D.

Saturday, September 7

8:30 a.m.: The Heart of the Matter: A Preventative Cardiologist's Perspective on Managing Type 2 Diabetes
Mikhail Kosiborod, M.D.

9:00 a.m.: New Treatments for Hypertriglyceridemia
Deepak Bhatt, M.D., M.P.H.

9:30 a.m.: Panel Q & A

10:15 a.m.: The Role of Revascularization in Stable Ischemic Heart Disease
Judith Hochman, M.D., M.A.

10:45 a.m.: Obesity, Inflammation, and Atherosclerosis
Alan Chait, M.D.

11:15 a.m.: Panel Q & A


Samuel J. Asirvatham, M.D.
Professor of Medicine and Pediatrics; Division of Pediatric Cardiology and Department of Physiology and Biomedical Engineering; Program Director, Electrophysiology Fellowship Program, Mayo Clinic College of Medicine


Ehrin Armstrong, M.D.
Associate Professor, Medicine-Cardiology; Director, Interventional Cardiology; Co-Director, Vascular Laboratory, VA Eastern Colorado Healthcare System


Deepak L. Bhatt, M.D., MPH, FACC, FAHA, FSCAI, FESC
Professor of Medicine, Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center, Harvard Medical School


Alan Chait, M.D.
Edwin L. Bierman Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington


Joaquin Cigarroa, M.D.
Head of the Division of Cardiovascular Medicine; Clinical Chief of Knight Cardiovascular Institute; Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine, Oregon Health & Science University


Maros Ferencik, M.D., Ph.D.
Associate Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine, Oregon Health & Science University


Satya (Tom) Sarma, M.D.
Assistant Professor of Internal Medicine, UT Southwestern Medical Center


Stephen Heitner, M.D.
Associate Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine, Oregon Health & Science University


Judith Hochman, M.D.
Professor of Cardiology; Associate Director, Division of Cardiology, Department of Medicine; Senior Associate Dean for Clinical Sciences; Director, Cardiovascular Clinical Research Center, NYU Langone Health


Mikhail Kosiborod, M.D.
Professor of Medicine, University of Missouri-Kansas City School of Medicine, St. Luke’s Health System


Michael Mack, M.D., F.A.C.C.
Medical Director, Cardiovascular Surgery, Baylor Health Care System; Chairman of Baylor Scott & White The Heart Hospital, Plano Research Center


Melvin Scheinman, M.D.
Professor of Medicine, Walter H. Shorenstein Endowed Chair in Cardiology, Chief of Cardiology Genetrics Arrhythmia Program


Firas Zahr, M.D.
Associate Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine; Director of Interventional Cardiology; Co-Director of Complex Heart Valve Program, Oregon Health & Science University